Global Stem Cell and Gene Therapy Biological Testing Market - Industry Trends and Forecast to 2028

Análise de mercado e insights do mercado de testes biológicos de células estaminais e terapia genética

A Data Bridge Market Research analisa que o mercado de testes biológicos de células estaminais e terapia genética apresentará um CAGR de cerca de 14,87% para o período de previsão de 2021-2028. O aumento das aprovações de instalações certificadas GMP para o fabrico de células estaminais, o aumento das atividades de investigação em células estaminais e o aumento das despesas públicas e privadas para o desenvolvimento de infraestruturas de saúde , especialmente nas economias emergentes, são os principais fatores atribuíveis ao crescimento do mercado de testes biológicos de células estaminais e terapia genética. Isto significa que o valor de mercado dos testes biológicos de células estaminais e da terapia genética, que era de 1.497,03 milhões de dólares em 2020, disparará para 4.538,22 milhões de dólares até ao ano de 2028.

A terapia com células estaminais está a ganhar proficiência no setor da saúde. A terapia com células estaminais é utilizada para prevenir uma doença ou qualquer condição, utilizando células estaminais. No entanto, a terapia genética incorporou o uso de genes para tratar qualquer condição ou prevenir doenças. Na terapia genética, os genes do paciente são modificados para curar qualquer doença predominante.  

O aumento da procura de produtos de terapia com células T CAR em todo o mundo é um dos principais fatores que induzem o crescimento da procura de testes biológicos de células estaminais e terapia genética. O aumento da prevalência de doenças crónicas, como o cancro, a diabetes, as doenças do sangue e outras doenças relacionadas com a imunidade irá gerar ainda mais oportunidades de crescimento lucrativas e remuneradas para o mercado de testes biológicos de células estaminais e terapia genética. A crescente consciencialização entre os doentes, juntamente com políticas de reembolso favoráveis ​​em mercados maduros, também atuarão como importantes determinantes do crescimento do mercado.  

No entanto, os elevados custos associados à terapia com células estaminais irão inviabilizar a taxa de crescimento do mercado dos testes biológicos com células estaminais e da terapia genética. Além disso, a ênfase em produtos de alta qualidade a baixos custos irá abrandar a taxa de crescimento do mercado. A disponibilidade de opções de tratamento alternativas também criará obstáculos.

This stem cell and gene therapy biological testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on stem cell and gene therapy biological testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Stem Cell and Gene Therapy Biological Testing Market Scope and Market Size

The stem cell and gene therapy biological testing market is segmented on the basis of product type and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

By product type, the global stem cell and gene therapy biological testing market is segmented into cell therapy and gene therapy.

• On the end users, the stem cell and gene therapy biological testing market is segmented into hospitals, wound care centres, cancer care centres, ambulatory surgical centres and others.

Stem Cell and Gene Therapy Biological Testing Market Country Level Analysis

The stem cell and gene therapy biological testing market is analysed and market size insights and trends are provided by product type and end users as referenced above.

The countries covered in the stem cell and gene therapy biological testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the stem cell and gene therapy biological testing market owing to the rising expenditure for research and development activities for the introduction safe and effective stem cell and gene therapy products coupled with favourable reimbursement scenario in the region. Asia-Pacific on the other hand is projected to undergo the highest growth rate during the forecast period owing to the rising prevalence of cancer and other chronic diseases and improving healthcare infrastructure.

The country section of the stem cell and gene therapy biological testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The stem cell and gene therapy biological testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the stem cell and gene therapy biological testing market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Stem Cell and Gene Therapy Biological Testing Market Share Analysis

The stem cell and gene therapy biological testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to stem cell and gene therapy biological testing market.

The major players covered in the stem cell and gene therapy biological testing market report are MEDIPOST, Smith & Nephew, ANTEROGEN.CO.,LTD., PHARMICELL Co., Ltd, JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., Gilead Sciences, Inc., Dendreon Pharmaceuticals LLC., Organogenesis Inc., Osiris., STEMCELL Technologies Inc., Athersys, Inc., Cryo-Cell, Astellas Pharma Inc., Cellular Engineering Technologies., Takara Bio Inc., LifeCell International Pvt. Ltd., Thermo Fisher Scientific Inc., AbbVie Inc. and BrainStorm Cell Limited. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-61713